Brain recordings to predict language development in children with autism
Follows young children with autism for 4 years using brain recordings.
Plain-language title generated from the registry record
Registry title: HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD
Key facts
- Where
- Étampes, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 4 years old?
Source: NCT05586672, who can take part
Where in France
- Etablissement Public de Santé Barthélemy DurandÉtampes, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Etablissement Public de Santé Barthélemy Durand
- Trial code
- NCT05586672
- Record updated
- 19 October 2022
- Original description
The goal of this prospective observational multicentric cohort study is to evaluate the clinical prognostic value of the speech tracking score of language development in children with ASD aged from 3 years to 4 years and half at inclusion.Read full original descriptionShow less
High Resolution Electroencephalogram Contribution in Prognostic Evaluation of Language Development in Children With Autism Spectrum Disorder
The goal of this prospective observational multicentric cohort study is to evaluate the clinical prognostic value of the speech tracking score of language development in children with ASD aged from 3 years to 4 years and half at inclusion.
Participants will followed during 4 years with an annual visit. During these visits, each participant will be clinically evaluated (scales and tests) and performed an EEG-HR recording. Two groups will be formed, one with children diagnosed with ASD with language delay, and a control group composed of non-ASD children without language delay, matched on age and gender with the ASD group.
Inclusion: For all participants; Child aged from 3 years to 4 years and half at inclusion; Information delivered and no parental objection for study participation; For ASD group; Diagnosis of ASD according to DSM-V criteria; Expressive language level < 27 months regarding on IDE scale; For Control group - Matched on age (at +/- 3 months) and gender to ASD group participants.
Exclusion: Any illness or treatment that could significantly alter EEG-HR recording (epilepsy, anti-epileptic treatment, psychotropic drugs...); Major hearing or vision disorders; For ASD group; Characterised neurological or psychiatric pathology; For all participants; Severe and characterised neurological pathology other than ASD; For Control group; Characteristic language delay.